1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

Large-vessel vasculitis (LVV) manifests as inflammation of the aorta and its major branches
and is the most common primary vasculitis in adults. LVV comprises two distinct conditions …

Objective To provide evidence‐based recommendations and expert guidance for the
management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large …

Background Since the publication of the European League Against Rheumatism (EULAR)
recommendations for the management of large vessel vasculitis (LVV) in 2009, several …

1.1. Purpose The European Society for Vascular Surgery (ESVS) appointed the Descending
Thoracic Aorta (DTA) Writing Committee (WC) to produce the current clinical practice …

Background GCA is a large vessel vasculitis affecting older people, with the highest
incidence among persons 70–79 years of age [1]. Due to forecasted demographic changes …

Background Giant cell arteritis is an immune-mediated disease of medium and large-sized
arteries that affects mostly people older than 50 years of age. Treatment with glucocorticoids …

Importance Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related
inflammatory disorders occurring in persons aged 50 years and older. Diagnostic and …

Objective To compare the efficacy of abatacept to that of placebo for the treatment of giant
cell arteritis (GCA). Methods In this multicenter trial, patients with newly diagnosed or …

Key Clinical Points Giant-Cell Arteritis and Polymyalgia Rheumatica The immune-mediated
diseases giant-cell arteritis and polymyalgia rheumatica occur in patients 50 years of age or …